2 completed, 1 active not recruiting, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Active not recruiting 1, Terminated 1 |
Follow Glomerulosclerosis, Focal Segmental: new trials by email Literature Review of Glomerulosclerosis, Focal Segmental trials Research Report on Glomerulosclerosis, Focal Segmental
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis Sparsentan - Proteinuria, Immunoglobulin A (IgA) Nephropathy | Phase 4 | Active not recruiting | Travere Therapeutics, Inc. | 20 | 2025-10-07 | 2026-06-23 |
| Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects Dapagliflozin - Focal Segmental Glomerulosclerosis | Phase 4 | Completed | University Health Network, Toronto | 10 | 2015-09-01 | 2018-01-16 |
| Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR) ACTHAR gel - Treatment Resistant Nephrotic Syndrome | Phase 4 | Completed | Columbia University | 15 | 2009-12-01 | 2014-04-24 |
| Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease Aliskiren, Valsartan - Proteinuric Kidney Disease, Diabetic Nephropathy | Phase 4 | Terminated | Columbia University | 46 | 2009-09-01 | 2014-05-15 |
Proteinuria (3) · Glomerulonephritis, IGA (2) · Glomerulonephritis, Membranous (2) · Diabetic Nephropathies (1) · Kidney Diseases (1) · Nephrosis, Lipoid (1) · Nephrotic Syndrome (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Glomerulonephritis (4) · Male Urogenital Diseases (4) · Nephritis (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Kidney Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Urination Disorders (3) · Urological Manifestations (3) · Autoimmune Diseases (2) · Immune System Diseases (2) · Chronic Disease (1)
Valsartan (1) · aliskiren (1) · dapagliflozin (1) · sparsentan (1)
Columbia University (2) · Travere Therapeutics, Inc. (1) · University Health Network, Toronto (1)
United States (3) · Canada (1)
Gerald B Appel, MD (1) · Pietro Canetta, MD (1) · Radko Komers, MD, PhD (1)